CIRM Funded Clinical Trials

Phase 1 Clinical research program for functional cure of HIV with EBT-101, in-vivo gene therapy

Disease Area:
HIV/AIDS
Investigator:
CIRM Grant:
CLIN2-13310 (Active)
Award Value:
$6,852,486.00
Trial Sponsor:
Excision BioTherapeutics
Trial Stage:
Phase 1
Trial Status:
Active, not recruiting
Targeted Enrollment:
6
ClinicalTrials.gov ID: